Sunday, December 4, 2022
Taysha Gene Therapies (NASDAQ: TSHA) Receives $50 Million Strategic Investment From Astellas Pharma to Develop AAV-Based Gene Therapeutics
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a biotechnology company that is focused on developing gene therapies to treat monogenic...
Read more
HOOKIPA Pharma (NASDAQ: HOOK) Enters into Collaboration Deal with Roche to Develop HB-700 For KRAS-Mutated Cancers
HOOKIPA Pharma, Inc. (NASDAQ: HOOK) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development...
Read more
Akouos (NASDAQ: AKUS) Enters Into Agreement to be Acquired by Eli Lilly (NYSE: LLY) at Valuation Up to $610 Million
Akouos, Inc. (NASDAQ: AKUS) is engaged as a precision genetic medicine company, which is focused on the research and development...
Read more
Applied DNA Sciences (NASDAQ: APDN) Receives Largest Purchase Order for LinearDNA Valued Over Mid-Six-Figures
Applied DNA Sciences, Inc. (NASDAQ: APDN) is engaged as a biotechnology company, which is focused on developing PCR-based DNA technologies....
Read more
HeartBeam (NASDAQ: BEAT) Unveils Cardiac Wearable Connectivity Feature that Can Turn Smartwatch Devices into Around-the-Clock Heart Monitoring Solutions
HeartBeam, Inc. (NASDAQ: BEAT) is engaged as a cardiac technology company, which leverages its line of proprietary algorithms to help...
Read more
PepGen (NASDAQ: PEPG) Shares Phase 1 Clinical Trial Results of PGN-EDO51 Showing Positive Data in Treating Duchenne Muscular Dystrophy
PepGen, Inc. (NASDAQ: PEPG) is engaged as a clinical-stage biotechnology company, which is focused on the research and development of...
Read more
LAVA Therapeutics (NASDAQ: LVTX) Enters into Global Licensing Agreement with Seagen (NASDAQ: SGEN) to Develop and Commercialize LAVA-1223
LAVA Therapeutics N.V. (NASDAQ: LVTX) is engaged as a clinical-stage oncology company, which is focused on the research and development...
Read more
Spero Therapeutics (NASDAQ: SPRO) Enters into Exclusive Licensing Agreement with GSK (NYSE: GSK) for the Commercialization of Tebipenem HBr
Spero Therapeutics, Inc. (NASDAQ: SPRO) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development and...
Read more
TRxADE Health (NASDAQ: MEDS) Subsidiary, Bonum Health Enters into Telehealth Services Deal with Wakefern Food Corp.
TRxADE Health, Inc. (NASDAQ: MEDS) is engaged as a health services IT company, which is focused on digitalizing the entire...
Read more
Akero Therapeutics (NASDAQ: AKRO) Squeezes Shorts After Stronger-then-Expected Results from Phase 2b HARMONY Study of EFX
Akero Therapeutics, Inc. (NASDAQ: AKRO) is engaged as a clinical-stage biotechnology company that is focused on the research and development...
Read more
